3 “Affordable Yet Compelling” Biotech Stocks With Bullish Analyst Reviews And Big Upside Potential

2020-06-27 11_57_21-Crop nurse with syringe on beige background · Free Stock PhotoClinical trial data or regulatory verdicts can send shares of biotech companies skyrocketing – or plummeting. The question then, as the author of today’s article observes, is “how are investors supposed to determine which biotech stocks are capable of outperforming the rest?” One approach is to track analyst sentiment – and the author highlights three biotech stocks that not only are analysts bullish on but which are trading for less than $5 a share and boast upside potential of over 100%. For more, CLICK HERE.

Read More

The Best Of Times To Bet On Biotech Penny Stocks?

2020-06-20 15_23_04-Coins Inside Jar · Free Stock Photo“Biotech penny stocks have always been a big focus for investors but this year has been one of the most active years for the sector,” observes the author of today’s article. And while the coronavirus outbreak has been a major reason for this increased activity, the author notes that “you also have companies hitting big milestones for other health indications.” With this being perhaps one of the best times to bet on biotech penny stocks, the author highlights four in particular to have a look at. For more, CLICK HERE.

Read More

Why This Cancer-Fighting Biotech With A Unique Name And Focus Belongs On Your Radar

2020-05-27 22_49_43-Pink Ribbons on Pink Surface · Free Stock PhotoThe “sleeper” biotech highlighted in today’s article, a company with a unique name and focused on therapies for very rare, pediatric cancers, has a promising pipeline – including two drugs that could be approved in the next year. This, combined with the fact that its stock price has steadily increased since its IPO (despite getting caught up in the coronavirus market sell-off), leads the author to recommend investors keep this company on their radars for potential buy the dip opportunities. For the biotech stock in question, CLICK HERE.

Read More

Should Biotech Stocks Come With A Warning Label At Current Levels?

2020-05-24 19_36_46-Woman in Gray Sweater Wearing Blue Framed Eyeglasses · Free Stock PhotoBiotech stocks have been experiencing a healthy bounce, with the largest ETF that tracks the group recently hitting an all-time high following the announcement from Moderna that it was seeing early positive results with its coronavirus vaccine candidate. Some traders are cautioning investors to “tread carefully” when it comes to buying in to biotech stocks at their current levels, however, pointing to “two very important names” in the aforementioned ETF that “are starting to break down.” For more, CLICK HERE.

Read More

2 Of The Most Promising Stocks In The Young – But Rapidly Growing – Gene Editing Space

2020-05-16 22_17_46-WindowWhen it comes to the nascent – but rapidly growing – gene editing space, the author of today’s article notes that “sector players are rapidly making progress in combating rare or difficult to treat diseases that traditional chemical based drugs simply cannot accomplish.” With the market for gene editing therapies expected to grow by over 18% annually, he highlights two of the most promising gene editing stocks for biotech investors to consider. For more, CLICK HERE.

Read More

Micro-Caps, Mega Gains?

2020-05-10 19_59_56-low angle photo of flag of U.S.A photo – Free City Image on UnsplashMorgan Stanley’s chief US equity strategist believes that stocks hit their true bottom on March 23rd – and that the current rally could well lead to a true recovery. To prepare for the next bull run, he’s advising clients to buy into small-cap stocks, so today’s article highlights “three micro-cap penny stock companies with super-low entry costs (a dollar per share or less) and huge upside potential (greater than 90% in the year to come).” For more, CLICK HERE.

Read More

Take Advantage Of This Stock Market Anomaly – And Outperform The Market!

2020-05-05 22_27_12-WindowToday’s article examines a particular, well-established anomaly of the stock market – the short-term reversal effect – and how active traders can use a simple rotational strategy to take advantage of this anomaly and significantly outperform the market. For more on the short-term reversal anomaly, the strategy to benefit directly from it – and whether traders can still use this strategy in these unusual times – CLICK HERE.

Read More